ES500122A0 - Procedimiento para preparar un producto con actividad de ti-po fibronectina - Google Patents

Procedimiento para preparar un producto con actividad de ti-po fibronectina

Info

Publication number
ES500122A0
ES500122A0 ES500122A ES500122A ES500122A0 ES 500122 A0 ES500122 A0 ES 500122A0 ES 500122 A ES500122 A ES 500122A ES 500122 A ES500122 A ES 500122A ES 500122 A0 ES500122 A0 ES 500122A0
Authority
ES
Spain
Prior art keywords
preparing
procedure
product
fibronectin
fibronectin activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES500122A
Other languages
English (en)
Other versions
ES8202029A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Cutter Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cutter Laboratories Inc filed Critical Cutter Laboratories Inc
Publication of ES8202029A1 publication Critical patent/ES8202029A1/es
Publication of ES500122A0 publication Critical patent/ES500122A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y10S530/831—Cohn fractions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES500122A 1980-03-05 1981-03-05 Procedimiento para preparar un producto con actividad de ti-po fibronectina Granted ES500122A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/127,340 US4341764A (en) 1980-03-05 1980-03-05 Method of preparing fibronectin and antihemophilic factor

Publications (2)

Publication Number Publication Date
ES8202029A1 ES8202029A1 (es) 1982-01-01
ES500122A0 true ES500122A0 (es) 1982-01-01

Family

ID=22429606

Family Applications (1)

Application Number Title Priority Date Filing Date
ES500122A Granted ES500122A0 (es) 1980-03-05 1981-03-05 Procedimiento para preparar un producto con actividad de ti-po fibronectina

Country Status (9)

Country Link
US (1) US4341764A (es)
EP (1) EP0035202B1 (es)
JP (1) JPS56139418A (es)
AT (1) ATE15973T1 (es)
CA (1) CA1164342A (es)
DE (1) DE3172567D1 (es)
DK (1) DK156697C (es)
ES (1) ES500122A0 (es)
MX (1) MX7113E (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440679A (en) * 1980-03-05 1984-04-03 Cutter Laboratories, Inc. Pasteurized therapeutically active protein compositions
JPS584074U (ja) * 1981-06-30 1983-01-11 井上　岱介 風車ネオン式検電器
DE3170868D1 (en) * 1981-10-12 1985-07-11 Armour Pharma Process for the preparation of highly purified antihemophilic factor
US4391749A (en) * 1981-10-19 1983-07-05 La Jolla Cancer Research Foundation Method for the purification of collagens
JPS5967228A (ja) * 1982-10-07 1984-04-16 Green Cross Corp:The 寒冷不溶性グロブリンの凍結乾燥方法
JPS59134732A (ja) * 1983-01-21 1984-08-02 Green Cross Corp:The フイブロネクチン・生理活性物質複合体の製造法
DE3318521A1 (de) * 1983-05-20 1984-11-22 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Verfahren zur herstellung eines antihaemophiliefaktor-konzentrats
EP0142109B1 (en) * 1983-11-04 1992-06-17 Ralph Silverman Macromolecules extracted from cultured mesenchymal cells for the treatment of degenerative diseases
US4965199A (en) * 1984-04-20 1990-10-23 Genentech, Inc. Preparation of functional human factor VIII in mammalian cells using methotrexate based selection
AT385658B (de) * 1985-03-28 1988-05-10 Serotherapeutisches Inst Wien Verfahren zur herstellung einer fuer die anwendung beim menschen geeigneten fibronektinloesung
US4587122A (en) * 1985-04-23 1986-05-06 The Green Cross Corporation Fibronectin-dextran-drug complex and method of preparation thereof
US4894328A (en) * 1986-03-26 1990-01-16 Board Of Regents, The University Of Texas System Immunodiagnostic test for syphilis and other treponemal infections
DK475386D0 (da) * 1986-10-03 1986-10-03 Weis Fogh Ulla Sivertsen Fremgangsmaade og apparat til fremstilling af biologiske stoffer
FR2632309B1 (fr) * 1988-06-07 1990-08-24 Lille Transfusion Sanguine Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus
US5629291A (en) * 1992-01-31 1997-05-13 La Jolla Cancer Research Foundation Methods of modulating fibronectin extracellular matrix assembly
US5453489A (en) * 1992-01-31 1995-09-26 La Jolla Cancer Research Foundation Polypeptide fragments of fibronectin which can modulate extracellular matrix assembly
US6528483B2 (en) * 1995-06-07 2003-03-04 André Beaulieu Method of producing concentrated non-buffered solutions of fibronectin
US7112320B1 (en) * 1995-06-07 2006-09-26 Andre Beaulieu Solid wound healing formulations containing fibronectin
US5821220A (en) * 1995-06-07 1998-10-13 Andre Beaulieu Method of producing concentrated non-buffered solutions of fibronectin
NZ505424A (en) 1998-01-23 2002-09-27 Csl Ltd Purification of fibrinogen
BR0008405B1 (pt) 1999-02-22 2014-04-22 Baxter Int Composição de fator viii formulada sem a adição de albumina, uso de uma composição de fator viii, e, método de liofilizar uma formulação farmacêutica aquosa
AU779126B2 (en) * 1999-12-23 2005-01-06 Csl Limited Separation of fibrinogen from plasma proteases
DE60042343D1 (de) * 1999-12-23 2009-07-16 Csl Ltd Abtrennung von fibrinogen von plasmaproteasen
DE102004044419B4 (de) 2004-09-14 2010-04-15 Biotest Ag Verfahren zur Aufreinigung eines von Willebrand Faktors mittels Hydroxylapatit-Durchlaufchromatographie
DE102004044429B4 (de) * 2004-09-14 2009-04-30 Biotest Ag Verfahren zur Herstellung einer Zusammensetzung enthaltend von Willebrand Faktor
US20100168018A1 (en) * 2008-11-07 2010-07-01 Baxter International Inc. Factor viii formulations
BRPI1010975B1 (pt) 2009-05-25 2021-08-24 H. Lundbeck A/S Métodos para preparar nalmefeno a partir de naltrexona em uma reação de wittig e para isolar o nalmefeno
IL213864A0 (en) 2011-06-30 2011-08-31 Omrix Biopharmaceuticals Ltd Method for removing a lytic enzyme from a heterogeneous mixture
US8844879B2 (en) * 2011-12-12 2014-09-30 The Boeing Company Wing variable camber trailing edge tip
IL231230A0 (en) 2014-02-27 2014-08-31 Omrix Biopharmaceuticals Ltd Fibrinogen preparation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3973002A (en) * 1974-04-12 1976-08-03 E. R. Squibb & Sons, Inc. Antihemophilic factor
US4170639A (en) * 1978-07-10 1979-10-09 Warner-Lambert Company Antihemophilic factor concentrate and its production
DE2848529A1 (de) * 1978-11-09 1980-05-29 Behringwerke Ag Verfahren zur herstellung des kaelteunloeslichen globulins und dieses enthaltende arzneimittel
US4278594A (en) * 1979-06-19 1981-07-14 David Amrani Process for separation and isolation of AHF, von Willebrand's ristocetin cofactor (VWF:RCF) and fibronectin from blood plasma
US4210580A (en) * 1979-06-19 1980-07-01 David Amrani Process for separation and isolation of AHF and fibronectin from blood plasma

Also Published As

Publication number Publication date
DK98581A (da) 1981-09-06
EP0035202B1 (en) 1985-10-09
EP0035202A3 (en) 1982-09-01
DE3172567D1 (en) 1985-11-14
ATE15973T1 (de) 1985-10-15
DK156697C (da) 1990-02-05
JPS56139418A (en) 1981-10-30
MX7113E (es) 1987-06-29
US4341764A (en) 1982-07-27
CA1164342A (en) 1984-03-27
ES8202029A1 (es) 1982-01-01
EP0035202A2 (en) 1981-09-09
DK156697B (da) 1989-09-25

Similar Documents

Publication Publication Date Title
ES500122A0 (es) Procedimiento para preparar un producto con actividad de ti-po fibronectina
DE3169544D1 (en) Process for the preparation of polyaddition products containing uret-dione groups, and products prepared by this process
DE3166441D1 (en) Novel antihistamines, process for their preparation and pharmaceutical compositions containing them
AU527434B2 (en) Microemulsion of nutrients for microorganisms
SG29883G (en) N-heterocyclyl-4-piperidinamines,methods for their preparation,pharmaceutical compositions comprising them,intermediates therefor,and method for the preparation of the intermediates
DE3069794D1 (en) Fermentation unit for the production of methane from plants
DE3571982D1 (en) Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds
ES462288A1 (es) Procedimiento para la obtencion de azabiciclohexanonas sus- tituidas.
ZA812949B (en) Process for the synthesis of o-chlorinated chloroformates, and new a-chlorinated chloroformates
AU547615B2 (en) Removal of degradation product from gas treating solution
DE3173499D1 (en) Novel thioesters and process for the preparation of the same
ES459295A1 (es) Procedimiento para la preparacion de antraquinon-bis-amidi- nas.
IT8022649A0 (it) Procedimento per la preparazionedi esteri alifatici non saturi da dieni alifatici.
SE8404334L (sv) 16-fluoro-16,17-didehydro-prostanoider och forfarande for deras framstellning
IT1092721B (it) Procedimento per la coltura di microrganismi
ES436513A1 (es) Un metodo para purificar extractos que contienen utero-eva- cuantes obtenidos a partir de la planta zoapatle.
JPS52125689A (en) Production of enzyme system for decomposing fibrinogen and medicine containing said system
AU546565B2 (en) Method of tissue culture
DE3064037D1 (en) Process for the preparation of alpha-oxo-alpha-(3-alkoxycarbonyl-2,2-dimethyl-cycloprop-1-yl) methane phosphoric acid esters, intermediate products therefor and process for their preparation
SU697563A1 (ru) Питательна среда дл выделени микроорганизмов-продуцентов амилаз
EP0137506A3 (en) Extraction of teichmonycin a2 from whole culture fermentation broth
JPS5660513A (en) Conveying method of dish
IT7850955A0 (it) Procedimento per la coltura aerobica di microorganismi
JPS5750823A (en) Forcing culture of lotus from lotus seed
JPS5415845A (en) Culture of fruittvegetable having hung fruit